z-logo
open-access-imgOpen Access
PLGA-based drug delivery system for combined therapy of cancer: research progress
Author(s) -
Ruirui Zhang,
Jian He,
Ximei Xu,
Shengxian Li,
Hongmei Peng,
Zhiming Deng,
Yong Huang
Publication year - 2021
Publication title -
materials research express
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.383
H-Index - 35
ISSN - 2053-1591
DOI - 10.1088/2053-1591/ac3f5e
Subject(s) - plga , drug delivery , aptamer , nanotechnology , polyethylene glycol , drug carrier , chitosan , cancer therapy , drug , controlled release , cancer , materials science , chemistry , pharmacology , biomedical engineering , nanoparticle , medicine , biochemistry , biology , genetics
In recent years, PLGA micro/nano particle drug delivery systems has been widely used in cancer treatment. According to the unique properties of PLGA, carriers of various structures are designed to keep the function of drugs or bioactive substances, ensure the effective load of molecules and improve the bioavailability of drugs in diseased parts. PLGA is one of the earliest and most commonly used biodegradable materials. It is often used for functional modification with other polymers (such as polyethylene glycol and chitosan) or other molecules (such as aptamers and ligands) to deliver various small molecule drugs (such as DOX and DTX) and bioactive macromolecules (such as proteins and nucleic acids) to improve targeting, controlled release and therapeutic properties. In this paper, the preparation methods, physical and chemical properties and medical applications of PLGA micro/nano particles are discussed. We focused on the recent research progress of the PLGA-based drug carrier system in tumor combination therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom